RI
Robert I Blum sold $401K of CYTK stock
Robert I Blum, President & CEO of Cytokinetics Inc (CYTK), sold 7,500 shares of CYTK stock worth $401K, per an SEC Form 4 filed Nov 19, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Nov 16, 2026, 3 days before it was made public.
CYTK has moved -3.2% since the trade date, from $53.17 to $51.46 (Nov 19, 2026 close).
- Traded
- Nov 16, 2026
- Disclosed
- Nov 19, 2026
- Filing delay
- 3 days
- Price since
- -3.2%
- Role
- President & CEO
- Source
- SEC Form 4